Pries J M, Gustafson A, Wiegand D, Duane W C
J Lipid Res. 1983 Feb;24(2):141-6.
Synthesis of bile salts is regulated through negative feedback inhibition by bile salts returning to the liver. Individual bile salts have not been distinguished with regard to inhibitory potential. We assessed inhibition of bile salt synthesis by either cholate or its taurine conjugate in bile fistula rats. After allowing synthesis to maximize, baseline synthesis was determined by measuring bile salt output in four consecutive 6-hr periods. Next, sodium cholate (+[(14)C]cholate) or taurocholate (+[(14)C]taurocholate) was infused into the jugular vein for 36 hr and bile was collected in 6-hr aliquots. Hepatic flux of exogenous bile salt was determined by measuring output of radioactivity in bile divided by specific activity of the infusate. Synthesis was determined during the last four 6-hr periods of infusion by subtracting exogenous bile salt secretion from the total bile salt output. Thirteen studies using cholate and 13 using taurocholate were performed. Hepatic flux of infused bile salt varied from 1 to 12 micro mol/100 g per rat per hr. Percent suppression of synthesis varied directly with hepatic flux of exogenous bile salt for both cholate and taurocholate in a linear fashion (r = 0.66, P < 0.01 and r = 0.87, P < 0.0005, respectively). Slope of the taurocholate line was 7.82 (% suppression/ micro mol per 100 g per hr), while slope of the cholate line was 3.66 (P < 0.05), indicating that taurocholate was approximately twice as potent as cholate in suppression of synthesis. At fluxes of 10-12 micro mol/100 g per hr, taurocholate suppressed synthesis 84 +/- 8 (SEM) % while cholate suppressed synthesis only 42 +/- 12% (P < 0.02). The x-intercept of the taurocholate line was 0.65 ( micro mol/100 g per hr), while that of the cholate line was -1.01 (NS) suggesting that the threshold for initial suppression of synthesis did not differ for these two bile salts. We conclude that taurocholate is a more effective inhibitor of hepatic bile salt synthesis than cholate, and that intestinal deconjugation of bile salts may play a role in the regulation of synthesis.-Pries, J. M., A. Gustafson, D. Wiegand, and W. C. Duane. Taurocholate is more potent than cholate in suppression of bile salt synthesis in the rat.
胆盐的合成通过返回肝脏的胆盐的负反馈抑制来调节。关于抑制潜力,尚未区分个别胆盐。我们评估了胆瘘大鼠中胆酸盐或其牛磺酸共轭物对胆盐合成的抑制作用。在使合成最大化后,通过在四个连续的6小时时间段内测量胆盐输出量来确定基线合成。接下来,将胆酸钠(+[(14)C]胆酸盐)或牛磺胆酸盐(+[(14)C]牛磺胆酸盐)注入颈静脉36小时,并以6小时的等分试样收集胆汁。通过测量胆汁中放射性输出量除以注入物的比活性来确定外源性胆盐的肝通量。在注入的最后四个6小时时间段内,通过从总胆盐输出量中减去外源性胆盐分泌量来确定合成量。进行了13项使用胆酸盐的研究和13项使用牛磺胆酸盐的研究。注入的胆盐的肝通量在每只大鼠每小时1至12微摩尔/100克之间变化。胆酸盐和牛磺胆酸盐对合成的抑制百分比均与外源性胆盐的肝通量呈线性直接变化(r分别为0.66,P <0.01和r = 0.87,P <0.0005)。牛磺胆酸盐线的斜率为7.82(抑制百分比/每100克每小时微摩尔),而胆酸盐线的斜率为3.66(P <0.05),这表明牛磺胆酸盐在抑制合成方面的效力约为胆酸盐的两倍。在通量为10 - 12微摩尔/100克每小时时,牛磺胆酸盐抑制合成84±8(SEM)%,而胆酸盐仅抑制合成42±12%(P <0.02)。牛磺胆酸盐线的x截距为0.65(微摩尔/100克每小时),而胆酸盐线的x截距为-1.01(无显著性差异),这表明这两种胆盐在合成初始抑制的阈值方面没有差异。我们得出结论,牛磺胆酸盐比胆酸盐更有效地抑制肝脏胆盐合成,并且胆盐的肠道去共轭作用可能在合成调节中起作用。-普里斯,J.M.,A.古斯塔夫森,D.维根德和W.C.杜安。牛磺胆酸盐在抑制大鼠胆盐合成方面比胆酸盐更有效。